In 2021, the global life sciences sector (including pharmaceuticals and medical devices) was valued at $1.25tn. This fast-growing sector brings immense opportunity but increased risk for participants.
Despite slowing GDP growth, rising inflation, increasing interest rates, Russia’s invasion of Ukraine and waning confidence in China’s economic outlook,...